Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 2;23:15330338241248576. doi: 10.1177/15330338241248576

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Differences in expression of CDX2 in ALL and AML, subtypes of AML, and primary cells from patients. (A) Comparison of CDX2 expression between patients with ALL and patients with AML according to the database. (B) CDX2 was highly expressed in AML-M6 compared with other AML subtypes. (C) The expression level of CDX2 in different disease stages in pediatric patients with AML was quantiﬁed by qRT-PCR. CDX2 expression was lower in CR patients compared with patients at diagnosis or with relapse. (*P < .05, **P < .01, ***P < .001).

Abbreviation: AML, acute myeloid leukemia.